Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

被引:129
作者
Hohmann, AG [1 ]
机构
[1] Univ Georgia, Biopsychol Program, Dept Psychol, Athens, GA 30602 USA
关键词
endocannabinoid; anandamide; pain; dorsal horn; dorsal root ganglia; spinal cord;
D O I
10.1016/S0009-3084(02)00154-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A large body of literature indicates that cannabinoids suppress behavioral responses to acute and persistent noxious stimulation. This review examines behavioral, neurophysiological and neuroanatomical evidence supporting a role for cannabinoids in suppressing nociceptive transmission at spinal and peripheral levels. The development of subtype-selective competitive antagonists and high-affinity agonists provides the pharmacological tools required to study cannabinoid antinociceptive mechanisms. These studies provide insight into the functional roles of cannabinoid receptor subtypes, CBI and CB2, in cannabinoid antinociceptive mechanisms as revealed in animal models of acute and persistent (somatic inflammatory; visceral inflammatory, neuropathic) pain. Localization studies employing receptor binding and quantitative autoradiography, immunocytochemistry and in situ hybridization are reviewed to examine the distribution of cannabinoid receptors at these levels and provide a neuroanatomical framework with which to understand the roles of endogenous cannabinoids in sensory processing. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:173 / 190
页数:18
相关论文
共 131 条
[101]   Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons [J].
Neumann, S ;
Doubell, TP ;
Leslie, T ;
Woolf, CJ .
NATURE, 1996, 384 (6607) :360-364
[102]   SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity [J].
Pan, XH ;
Ikeda, SR ;
Lewis, DL .
MOLECULAR PHARMACOLOGY, 1998, 54 (06) :1064-1072
[103]  
PRICE TJ, 2001, SOC NEUR ABST, V31
[104]  
RICE AS, 2002, FATTY ACIDS, V66, P243
[105]   Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors [J].
Richardson, JD ;
Kilo, S ;
Hargreaves, KM .
PAIN, 1998, 75 (01) :111-119
[106]   Antihyperalgesic effects of spinal cannabinoids [J].
Richardson, JD ;
Aanonsen, L ;
Hargreaves, KM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 345 (02) :145-153
[107]  
Richardson JD, 1998, J NEUROSCI, V18, P451
[108]  
Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644
[109]   SR141716A, A POTENT AND SELECTIVE ANTAGONIST OF THE BRAIN CANNABINOID RECEPTOR [J].
RINALDICARMONA, M ;
BARTH, F ;
HEAULME, M ;
SHIRE, D ;
CALANDRA, B ;
CONGY, C ;
MARTINEZ, S ;
MARUANI, J ;
NELIAT, G ;
CAPUT, D ;
FERRARA, P ;
SOUBRIE, P ;
BRELIERE, JC ;
LEFUR, G .
FEBS LETTERS, 1994, 350 (2-3) :240-244
[110]   Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception [J].
Ross, RA ;
Coutts, AA ;
McFarlane, SM ;
Anavi-Goffer, S ;
Irving, AJ ;
Pertwee, RG ;
MacEwan, DJ ;
Scott, RH .
NEUROPHARMACOLOGY, 2001, 40 (02) :221-232